The Company is pleased to advise that its underwritten non-renounceable pro-rata rights issue (ASX release 18 April 2019) closed at 5:00pm (ACST) on 10 May 2019.

The Company received acceptances for 371,111,697 new shares at an issue price of $0.006 per share for a total $2,226,670, representing an approximate 41% take-up (including oversubscriptions). This included participation by a number of major shareholders, including DELPHI Unternehmensberatung Aktiengesellschaft (“DELPHI”) which took up its full entitlement together with the Board and management of the Company.

Pursuant to the underwriting agreement, DELPHI will be allocated the remaining shortfall of 539,073,425 shares for a total consideration of $3,234,441.